GRAIL, Inc. Operating Lease, Payments
GRAIL, Inc. (GRAL) reported Operating Lease, Payments of $8.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-06
- GRAIL, Inc. operating lease, payments for the quarter ending 2026-06-30 was $4.09M, a 4.63% decline year-over-year.
- GRAIL, Inc. operating lease, payments for the quarter ending 2026-03-31 was $4.43M, a 1.21% increase year-over-year.
- GRAIL, Inc. operating lease, payments for the quarter ending 2025-12-31 was $4.50M, a 0.04% increase year-over-year.
- GRAIL, Inc. operating lease, payments for the quarter ending 2025-09-30 was $4.00M, a 15.39% decline year-over-year.
- GRAIL, Inc. operating lease, payments for fiscal 2025 was $17.17M, a 10.89% decline from fiscal 2024.
- GRAIL, Inc. operating lease, payments for fiscal 2024 was $19.27M, a 2.88% increase from fiscal 2023.
- GRAIL, Inc. operating lease, payments for fiscal 2023 was $18.73M, a 6.83% increase from fiscal 2023.
- GRAIL, Inc. operating lease, payments for fiscal 2023 was $17.54M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $8.53M 10-Q · filed 2026-08-06 | $13.03M derived: sum of 3 quarters · filed 2026-08-06 | $17.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $4.43M 10-Q · filed 2026-05-07 | $8.93M derived: sum of 2 quarters · filed 2026-05-07 | $12.93M derived: sum of 3 quarters · filed 2026-05-07 | $17.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $8.50M derived: sum of 2 quarters · filed 2026-03-12 | $12.80M derived: sum of 3 quarters · filed 2026-08-06 | $17.17M 10-K · filed 2026-03-12 |
| 2025-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $8.30M derived: sum of 2 quarters · filed 2026-08-06 | $12.67M 10-Q · filed 2025-11-13 | $17.17M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $4.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $8.67M 10-Q · filed 2026-08-06 | $13.17M derived: sum of 3 quarters · filed 2026-08-06 | $17.90M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $4.38M 10-Q · filed 2026-05-07 | $8.88M derived: sum of 2 quarters · filed 2026-05-07 | $13.61M derived: sum of 3 quarters · filed 2026-05-07 | $18.64M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $9.23M derived: sum of 2 quarters · filed 2026-03-12 | $14.27M derived: sum of 3 quarters · filed 2026-03-12 | $19.27M 10-K · filed 2026-03-12 |
| 2024-09-30 | $4.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $9.77M derived: sum of 2 quarters · filed 2025-11-13 | $14.77M 10-Q · filed 2025-11-13 | $19.61M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | $5.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $10.04M 10-Q · filed 2025-08-13 | $14.88M derived: sum of 3 quarters · filed 2026-03-12 | $19.66M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | $5.00M 10-Q · filed 2025-05-14 | $9.84M derived: sum of 2 quarters · filed 2026-03-12 | $14.62M derived: sum of 3 quarters · filed 2026-03-12 | |
| 2023-12-31 | $4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $9.62M derived: sum of 2 quarters · filed 2026-03-12 | $18.73M 10-K · filed 2025-03-05 | |
| 2023-10-01 | $4.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $13.90M 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $9.12M 10-Q · filed 2024-08-13 | |||
| 2023-01-01 | $17.54M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |